DAPAGLIFLOZIN VERSUS SACUBITRIL-VALSARTAN FOR HEART FAILURE WITH MILDLY REDUCED OR PRESERVED EJECTION FRACTION

被引：0
|
作者：
Arbel, Ronen [1 ]
Oberoi, Mansi [1 ]
Alnsasra, Hilmi [1 ]
机构：
[1] Univ Nebraska Med Ctr, Omaha, NE USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2024年 / 83卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1404-129
引用
收藏
页码：628 / 628
页数：1
相关论文
共 50 条
  • [41] Sacubitril/Valsartan and Frailty in Patients With Heart Failure and Preserved Ejection Fraction
    Butt, Jawad H.
    Dewan, Pooja
    Jhund, Pardeep S.
    Anand, Inder S.
    Atar, Dan
    Ge, Junbo
    Desai, Akshay S.
    Echeverria, Luis E.
    Kober, Lars
    Lam, Carolyn S. P.
    Maggioni, Aldo P.
    Martinez, Felipe
    Packer, Milton
    Rouleau, Jean L.
    Sim, David
    Van Veldhuisen, Dirk J.
    Vrtovec, Bojan
    Zannad, Faiez
    Zile, Michael R.
    Gong, Jianjian
    Lefkowitz, Martin P.
    Rizkala, Adel R.
    Solomon, Scott D.
    McMurray, John J., V
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 80 (12) : 1130 - 1143
  • [42] Sacubitril/valsartan in an experimental model of heart failure with preserved ejection fraction
    De Angelis, A.
    Cappetta, D.
    Telesca, M.
    Bellocchio, G.
    Urbanek, K.
    Berrino, L.
    CARDIOVASCULAR RESEARCH, 2022, 118 (SUPPL 1)
  • [43] Dapagliflozin in heart failure with preserved and mildly reduced ejection fraction: rationale and design of the DELIVER trial
    Solomon, Scott D.
    de Boer, Rudolf A.
    DeMets, David
    Hernandez, Adrian F.
    Inzucchi, Silvio E.
    Kosiborod, Mikhail N.
    Lam, Carolyn S. P.
    Martinez, Felipe
    Shah, Sanjiv J.
    Lindholm, Daniel
    Wilderang, Ulrica
    Ohrn, Fredrik
    Claggett, Brian
    Langkilde, Anna Maria
    Petersson, Magnus
    McMurray, John J. V.
    EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 (07) : 1217 - 1225
  • [44] Dapagliflozin: a potential lifesaver for "heart failure patients with mildly reduced or preserved ejection fraction" in the world
    Bijarani, Faizan Shafqat Ali
    Nazeer, Ahsan
    Shaikh, Bisma
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2023, 73 (12) : 2529 - 2529
  • [45] Rationale and design of Dapagliflozin vErsus SacubiTrIl-valsartaN therapY in Heart Failure with reduced ejection fraction (DESTINY-HF): a pragmatic randomised controlled trial protocol
    Tiwari, Krishna
    Deora, Surender
    Choudhary, Rahul
    Kaushik, Atul
    Dwivedi, Pradeep
    Singh, Surjit
    Ambwani, Sneha
    Midha, Naresh
    Shukla, Ravindra
    Sankanagoudar, Shrimanjunath
    Shamim, Muhammad Aaqib
    Tiwari, Vikas Kumar
    Yadav, Isha
    Dodiya, Rakesh
    Varthya, Shoban Babu
    BMJ OPEN, 2024, 14 (10):
  • [46] Dapagliflozin and diuretic utilization in heart failure with mildly reduced or preserved ejection fraction: the DELIVER trial
    Chatur, Safia
    Vaduganathan, Muthiah
    Claggett, Brian
    Vardeny, Orly
    Desai, Akshay S.
    Jhund, Pardeep S.
    de Boer, Rudolf A.
    Lam, Carolyn S. P.
    Kosiborod, Mikhail N.
    Shah, Sanjiv J.
    Martinez, Felipe
    Inzucchi, Silvio E.
    Hernandez, Adrian F.
    Haddad, Tariq
    Mitter, Sumeet S.
    Miao, Zi Michael
    Petersson, Magnus
    Langkilde, Anna Maria
    McMurray, John J., V
    Solomon, Scott D.
    EUROPEAN HEART JOURNAL, 2023, 44 (31) : 2930 - 2943
  • [47] Sacubitril-Valsartan Treatment Improves Vascular Function And Functional Capacity In Heart Failure With Reduced Ejection Fraction
    Bunsawat, Kanokwan
    Ratchford, Stephen M.
    Alpenglow, Jeremy K.
    Park, Soung Hun
    Jarrett, Catherine L.
    Stehlik, Josef
    Smith, Adam
    Richardson, Russell S.
    Wray, D. Walter
    MEDICINE & SCIENCE IN SPORTS & EXERCISE, 2020, 52 (07) : 236 - 236
  • [48] Combined treatment with sacubitril/valsartan plus dapagliflozin in patients affected by heart failure with reduced ejection fraction
    Jiang, Juan
    Gao, Jie
    Zhang, Xiuzhen
    Li, Yuanmin
    Dang, Heqin
    Liu, Yanlin
    Chen, Wenwen
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 10
  • [49] Sacubitril-valsartan modifies the indication of cardiac implantable devices in patients with heart failure and reduced ejection fraction
    Belarte-Tornero, Laia Carla
    Mojon, Diana
    Sole-Gonzalez, Eduard
    Ruiz-Bustillo, Sonia
    Valdivielso-More, Sandra
    Farre, Nuria
    REVISTA ESPANOLA DE CARDIOLOGIA, 2021, 74 (12): : 1118 - +
  • [50] Can Sacubitril-valsartan Improve Locomotor Muscle Microvascular Function In Heart Failure With Reduced Ejection Fraction?
    Bunsawat, Kanokwan
    Ratchford, Stephen M.
    Alpenglow, Jeremy K.
    Jarrett, Catherine L.
    Iacovelli, Jarred J.
    Park, Soung Hun
    Stehlik, Josef
    Smith, Adam S.
    Wray, D. Walter
    MEDICINE & SCIENCE IN SPORTS & EXERCISE, 2024, 56 (10) : 36 - 36
12345